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Abstract
Background: Non-obstructive coronary artery disease (CAD) is as-
sociated with significantly increased risk for myocardial infarction. 
Heart rate recovery (HRR), a measure of autonomic function, is a 
strong predictor of all-cause mortality. Microalbuminuria, a marker of 
early arterial disease, is an independent risk factor for cardiovascular 
disease and mortality. We aimed to investigate HRR and determine its 
relationship with microalbuminuria in patients with non-obstructive 
CAD.
Methods: We prospectively studied 565 patients who underwent 
elective coronary angiography. All participants underwent urinary 
analysis and then an exercise test. Microalbuminuria was defined as 
an urinary albumin-to-creatinine ratio (UACR) of 30 - 299 mg/g. The 
HRR was abnormal if ≤ 12 beats/min during the first minute after 
exercise. First, all patients were divided into two groups, patients with 
microalbuminuria (n = 152) and patients without microalbuminuria (n 
= 413). Then, all patients were re-divided into two groups, those with 
lower HRR (≤ 12 beats/min, n = 126) and those with higher HRR (> 
12 beats/min, n = 439).
Results: Patients with microalbuminuria had lower HRR and patients 
with lower HRR had higher UACR. While UACR was negatively 
correlated with HRR in patients with microalbuminuria (r = -0.424; P 
< 0.001) and in patients with lower HRR (r = -0.192; P= 0.042), there 
was no correlation of UACR with HRR in neither patients with nor-
moalbuminuria nor patients with higher HRR, respectively. In the all 
study population, there was a significant inverse association between 
UACR and HRR (r = -0.445, P < 0.001), and UACR independently 
predicted the presence of lower HRR (P < 0.001).
Conclusions: Our findings showed that there was a significant in-
verse association between UACR and HRR in patients especially 
with microalbuminuria, and that albuminuria might predict cardiac 
autonomic imbalance evaluated by HRR in patients with non-obstruc-
tive CAD.
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Introduction
Coronary artery disease (CAD) is a chronic and progressive 
disease. Clinically significant CAD (defined as one or more le-
sions with ≥ 50% stenosis in the left main or ≥ 70% stenosis in 
any other epicardial coronary artery on coronary angiogram) is 
often symptomatic. Non-obstructive CAD has a long asympto-
matic phase, is usually left untreated, but it could culminate in 
acute clinical coronary events just like obstructive CAD [1-3].
Microalbuminuria, described as small quantities of albu-
min in the urine ranging between 30 and 300 mg/dL per day 
(20 - 200 mg/min), is an easily measurable parameter. Microal-
buminuria reflects vascular damage and appears to be a marker 
of early arterial disease and endothelial dysfunction [4]. In-
creased urinary albumin excretion is a powerful predictor of 
cardiovascular disease and mortality in diabetic, hypertensive 
and elderly individuals, and in the apparently healthy general 
population [5-8].
Heart rate recovery (HRR) after exercise test, as a sim-
ple method for evaluating the effects of autonomic function 
on the cardiovascular system, has been shown to be affected 
in patients with CAD [9-13]. HRR has recently emerged as a 
powerful predictor of mortality [12, 13]. The predictive ability 
of HRR has been shown to be independent of the angiographic 
severity of coronary disease [13].
There have been insufficient data about non-obstructive 
CAD and its outcomes. To determine which individuals with 
non-obstructive CAD are at low or high risk for developing 
cardiac events may be of clinical importance. The use of mi-
coalbuminuria had been recommended in hypertensive patients 
with or without diabetes mellitus [14]. A better understanding 
of the relationship of HRR with microalbuminuria could help 
better risk stratify those patients at high risk of coronary events.
We hypothesized that abnormal HRR might be related 
to microalbuminuria in non-obstructive CAD. Therefore, we 
aimed to evaluate HRR, and determine its relationship with 
microalbuminuria in patients with non-obstructive CAD.
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Materials and Methods
The study design was prospective. The study included 565 
consecutive patients who underwent an elective coronary an-
giography due to the suspicion of CAD from August 2014 to 
December 2016. All participants had a thorough medical his-
tory, physical examination, and electrocardiographic, echocar-
diographic, angiographic evaluations and laboratory analyses. 
Exclusion criteria were diabetes mellitus (defined as fasting 
plasma glucose ≥ 126 mg/dL or 2-h plasma glucose ≥ 200 mg/
dL or the use of antidiabetic drugs), hypertension (defined as 
blood pressure of ≥ 140/90 mm Hg or the use of antihyperten-
sive drugs), heavy smoking (described as smoking ≥ 20 ciga-
rettes per day), reduced renal function (serum creatinine level 
≥ 1.5 mg/dL) or renal diseases, macroalbuminuria (defined 
as an urinary albumin excretion rate ≥ 300 mg/day), hepatic 
disease, aortic disease, peripheral arterial disease, congenital 
heart disease, ventricular hypertrophy, slow coronary flow, 
previous coronary or valvular intervention and/or cardiac sur-
gery, myocardial disease, systolic dysfunction (ejection frac-
tion < 50%), digoxin use, left bundle branch block, cardiac 
arrhythmias, moderate or severe (> 2+) valvular regurgitation 
or any valvular stenosis, thyroid disorders, recent invasive sur-
gery, obesity (body mass index > 30 kg/m2), the use of any 
anti-inflammatory medication, autoimmune and inflamma-
tory diseases with clinical or biochemical evidence. We also 
excluded patients who had contraindications to exercise test-
ing, and failed to reach 85% of their age-predicted maximal 
heart rate during exercise test. All participants gave the writ-
ten informed consent. The study protocol complied with the 
Declaration of Helsinki and was approved by the Pamukkale 
University Medical Ethics Committee (registration number: 
60116787-020/39556, date of issue: July 11, 2014).
Laboratory analyses
All blood samples were drawn after a 12-h overnight fasting for 
total cholesterol (TC), triglyceride (TG), high-density lipopro-
tein-cholesterol (HDL-C), low-density lipoprotein-cholesterol 
(LDL-C), complete blood count (CBC), glucose and creati-
nine. Assays for cholesterol profile and creatinine were car-
ried out using a Cobas Integra 800 automated analyzer (Roche 
Diagnostics, Mannheim, Germany). The glomerular filtration 
rate (GFR) was calculated as a function of age, serum creati-
nine, and race using the simplified modified diet in renal dis-
ease (MDRD) equation (eGFR (mL/min/1.73 m2) = 186.3 × 
creatinine-1.154 × age-0.203 × (0.742 if female)). High-sensitivity 
C-reactive protein (hsCRP) was analyzed using a method of 
latex turbidimetric immunoassay, with the minimum limit of 
detection at 0.15 mg/L (Cobas C Systems, Roche-Hitachi, Rot-
kreuz, Switzerland). The hsCRP less than 3 mg/L was accepted 
as normal.
Coronary angiography
Coronary angiographies were performed with a femoral or ra-
dial approach using the standard Judkins technique through a 
6-F introducer sheath. Consistent with the current literature, 
non-obstructive CAD was defined as a coronary artery stenosis 
20% or greater but less than 50% in the left main coronary ar-
tery (LMCA) or a stenosis 20% or greater but less than 70% in 
any other epicardial coronary artery [2, 3]. The extent and se-
verity of CAD were evaluated by the Gensini score [15], which 
is based on the percentage of luminal narrowing (1-25%: 1 
point; 26-50%: 2 points; 51-75%: 4 points; 76-90%: 8 points; 
91-99%: 16 points, and 100%: 32 points). This score was then 
multiplied by a factor according to the functional importance 
of the myocardial area supplied by that segment. The multipli-
cation factor is 5 for the LMCA; 2.5 for proximal left anterior 
descending coronary artery (LAD); 2.5 for proximal circum-
flex artery (CX); 1.5 for mid-LAD, and 1 for distal LAD, and 
mid/distal CX artery, and all segments of the right coronary 
artery; and 0.5 for other coronary segments. Finally, the Gensi-
ni score was obtained by summation of individual coronary 
segment scores. Furthermore, the number of diseased coronary 
arteries (DCA) was represented as one-, two- and three-vessel 
involvement. Gensini score and the number of DCA were re-
corded by a cardiologist who was blinded to study grouping, 
exercise and laboratory findings.
Urinary analyses
Urinary tests were done at the end of second week after coro-
nary angiography. Early morning midstream urine sample was 
collected and analyzed. Urinary creatinine was measured using 
a modified Jaffe method. Urinary albumin was determined us-
ing an immunonephelometry method. Microalbuminuria was 
accepted as persistent if the urinary albumin-to-creatinine ratio 
(UACR) was in the range of 30 - 299 mg/g in at least two of 
three consecutive samples [4].
Heart rate recovery and Duke treadmill score
Within 2 days after completion of urinary analyses, all par-
ticipants underwent the standard or symptom-limited treadmill 
test, with a goal of achieving at least 85% of the age-predicted 
maximum heart rate (220 - age). Certain medications such as 
beta-blocker and calcium channel antagonists that may af-
fect exercise test results were discontinued for 72 h prior to 
the test. Participants were encouraged to exercise until they 
experienced limiting symptoms. During each exercise stage 
and every minute for 3 min after recovery, heart rate, cardiac 
rhythm, and blood pressure were recorded. After peak exer-
cise, subjects walked a 2-min cool-down period at a speed 
of 1.5 mph and a grade of 2.5%. HRR was described as the 
change in heart rate from peak exercise to 1 min after exercise. 
HRR of 12 beats/min or less was defined as abnormal [9-11]. 
In addition, the Duke treadmill score (DTS) was calculated for 
each participant according to the following formula: DTS = 
(exercise duration in minutes) - (5 × ST deviation in millime-
ters) - (4 × treadmill angina index). The treadmill angina index 
is equal to 0 for no exercise angina, 1 for exercise-non-limiting 
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angina, and 2 for exercise-limiting angina [16, 17]. HRR and 
DTS were recorded by another cardiologist who was blinded 
to study grouping, angiographic and laboratory findings.
Statistical methods
The statistical analyses were done using the SPSS software 
package (version 20.0; IBM, SPSS Inc., Chicago, IL, USA). 
All enrolled patients were divided into two groups based on 
microalbuminuria: non-obstructive CAD patients with mi-
croalbuminuria (n = 152) vs. non-obstructive CAD patients 
without microalbuminuria (n = 413). Categorical variables are 
shown as frequencies and percentage values, and comparisons 
were made using a Chi-square test or Fisher’s exact test. The 
distribution of data was checked with Kolmogorov-Smirnov 
test. Continuous variables are shown as mean ± SD, and were 
compared between groups using independent t-test (for nor-
mally distributed variables) or a Mann-Whitney U test (for 
variables not normally distributed). Pearson’s or the Spear-
man correlation analysis was used to detect the relationship 
between variables. To describe the independent predictors of 
the presence of lower HRR value (≤ 12 beats/min), all study 
participants were subsequently stratified into the two groups 
according to the values of HRR (≤ 12 beats/min, n = 126 vs. > 
12 beats/min, n = 439). All variables with a P value of < 0.05 
in the univariate analysis were entered into the multivariate 
logistic regression analysis. The variables “one-vessel, two-
vessel and three-vessel involvement” were not included as a 
covariate in the multivariate analysis because of collinearity 
with the variable “the number of diseased coronary arteries”, 
which was used instead. The results are shown as odds ratio 
Table 1.  Baseline Clinical, Demographic and Laboratory Characteristics of Non-Obstructive Coronary Artery Disase Patients With 
and Without Microalbuminuria
Variables
Non-obstructive coronary artery disease
P value
With microalbuminuria (n = 152) Without microalbuminuria (n = 413)
Age (years) 55 ± 6 53 ± 7 0.107
Female, n (%) 63 (41%) 153 (37%) 0.340
SBP (mm Hg) 130 ± 9 128 ± 10 0.013
DBP (mm Hg) 80 ± 7 78 ± 7 0.006
BMI (kg/m2) 28.0 ± 2.1 27.7 ± 2.2 0.058
Family history, n (%) 10 (9.8%) 29 (7.0%) 0.854
Ejection fraction (%) 61 ± 6 62 ± 4 0.590
Total cholesterol (mg/dL) 211 ± 28 208 ± 26 0.288
HDL (mg/dL) 48 ± 8 48 ± 9 0.700
LDL (mg/dL) 126 ± 26 123 ± 27 0.334
Triglyceride (mg/dL) 185 ± 40 180 ± 41 0.242
Glucose (mg/dL) 92 ± 9 90 ± 9 0.134
Creatinine (mg/dL) 0.91 ± 0.16 0.89 ± 0.14 0.151
eGFR (mL/min/1.73 m2) 85 ± 20 88 ± 21 0.106
hsCRP (mg/L) 4.1 ± 2.3 3.5 ± 2.2 0.005
UACR (mg/g) 92 ± 27 8 ± 3 < 0.001
Gensini score 64 ± 37 44 ± 25 < 0.001
The number of DCA 2.2 ± 0.7 2.0 ± 0.7 0.012
  One-vessel, n (%) 32 (28%) 109 (52%) 0.194
  Two-vessel, n (%) 63 (46%) 201 (36%) 0.127
  Three-vessel, n (%) 57 (26%) 103 (12%) 0.003
Baseline heart rate, beats/min 70 ± 11 68 ± 12 0.576
Max heart rate, beats/min 154 ± 9 156 ± 10 0.007
HR1, beats/min 139 ± 10 133 ± 13 < 0.001
HRR, beats/min 15 ± 7 24 ± 9 < 0.001
Duke treadmill score 4.1 ± 8.1 7.1 ± 7.2 < 0.001
BMI: body mass index; DCA: diseased coronary arteries; DBP: diastolic blood pressure; HDL: high-density lipoprotein; HR1: heart rate at first minute; 
HRR: heart rate recovery; hsCRP: high-sensitive C-reactive protein; LDL: low-density lipoprotein; eGFR: estimated glomerular filtration rate; SBP: 
systolic blood pressure; UACR: urinary albumin-to-creatinine ratio.
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(OR) with 95% confidence interval (CI). Receiver operating 
characteristic (ROC) analysis was constructed to calculate the 
area under the curve (AUC) and define the best cutoff points 
of UACR to predict the lower values of HRR (≤ 12 beats/min), 
with the maximal sensitivity and specificity. The differences 
with probability values (P) of less than 0.05 were considered 
as significant.
Results
A total of 565 patients (349 male, 61.8%) were enrolled. All 
patients had non-obstructive CAD. The mean age was 54 ± 7 
years, the mean UACR was 31 ± 40 mg/g, and the mean HRR 
was 21 ± 9 beats/min. In the all study population, there was a 
significant inverse association between UACR and HRR (r = 
-0.445, P < 0.001). Baseline clinical, demographic, and labo-
ratory characteristics were compared between non-obstructive 
CAD patients with and without microalbuminuria (Table 1). 
The two groups were similar regarding age, sex, family history 
(FH), ejection fraction (EF), glucose, lipid profile, creatinine, 
eGFR, body mass index (BMI), and baseline heart rate. Pa-
tients with microalbuminuria had higher systolic blood pres-
sure (SBP), diastolic blood pressure (DBP), UACR and hsCRP. 
Patients with microalbuminuria had also greater Gensini score 
and the number of DCA. Maximum heart rate, and heart rate at 
first minute after exercise were significantly greater in patients 
with microalbumuria than in patients without microalbumuria. 
HRR and DTS were significantly lower in patients with micro-
albumuria than in patients without microalbumuria. In patients 
with microalbumuria, UACR was positively correlated with 
hsCRP (r = 0.426; P < 0.001), Gensini score (r = 0.423; P < 
0.001) and the number of DCA (r = 0.247; P < 0.001), and 
negatively correlated with HRR (r = -0.424; P < 0.001) and 
DTS (r = -0.334; P < 0.001). In addition, hsCRP was nega-
tively correlated with HRR (r = -0.360; P < 0.001) and DTS 
(r = -0.319; P < 0.001) in patients with microalbumuria. There 
were no associations among the above-mentioned variables 
Table 2.  Baseline Clinical, Demographic and Laboratory Characteristics of the Patients According to the Values of HRR 
(≤ 12 beats/min vs. > 12 beats/min)
Variables
Heart rate recovery
P value
≤ 12 (n = 126) > 12 (n = 439)
Age (years) 55 ± 7 54 ± 7 0.021
Female, n (%) 46 (37%) 170 (39%) 0.652
Systolic blood pressure (mm Hg) 129 ± 10 128 ± 9 0.061
Diastolic blood pressure (mm Hg) 79 ± 8 78 ± 7 0.225
BMI (kg/m2) 27.9 ± 2.1 27.6 ± 2.2 0.236
Ejection fraction (%) 61 ± 5 62 ± 5 0.170
Total cholesterol (mg/dL) 213 ± 28 207 ± 25 0.069
HDL (mg/dL) 47 ± 9 48 ± 8 0.101
LDL (mg/dL) 129 ± 28 122 ± 26 0.009
Triglyceride (mg/dL) 190 ± 44 178 ± 39 0.006
Glucose (mg/dL) 92 ± 9 90 ± 9 0.036
Creatinine (mg/dL) 0.90 ± 0.13 0.88 ± 0.15 0.629
eGFR (mL/min/1.73 m2) 86 ± 19 87 ± 20 0.547
hsCRP (mg/L) 4.8 ± 2.8 3.3 ± 2.0 < 0.001
UACR (mg/g) 54 ± 50 24 ± 34 < 0.001
Gensini score 62 ± 36 46 ± 27 < 0.001
The number of DCA 2.1 ± 0.7 2.0 ± 0.7 0.012
  One-vessel involvement, n (%) 18 (14.3%) 123 (28%) 0.002
  Two-vessel involvement, n (%) 61 (48.4%) 203 (46%) 0.667
  Three-vessel involvement, n (%) 47 (37.3%) 113 (26%) 0.014
Baseline heart rate, beats/min 71 ± 13 69 ± 11 0.076
HRR, beats/min 9 ± 2 25 ± 7 < 0.001
Duke treadmill score 4.4 ± 7.9 6.8 ± 7.3 0.001
BMI: body mass index; DCA: diseased coronary arteries; HDL: high-density lipoprotein; HRR: heart rate recovery; hsCRP: high-sen-
sitive C-reactive protein; LDL: low-density lipoprotein; eGFR: estimated glomerular filtration rate; UACR: urinary albumin-to-creatinine 
ratio.
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in patients without microalbumuria. Table 2 shows the clini-
cal, demographic, and laboratory data of each subgroup after 
grouping by HRR values (≤ 12 beats/min vs. > 12 beats/min). 
There were no statistically significant differences in terms of 
gender, FH, EF, SBP, DBP, BMI, creatinine, eGFR and base-
line heart rate between patients with lower (≤ 12 beats/min) and 
higher (> 12 beats/min) HRR values. Patients with abnormal 
or lower HRR tended to be older and had higher LDL, triglyc-
eride and glucose levels. UACR, hsCRP, Gensini score and the 
number of DCA were higher, and DTS was lower in patients 
with lower HRR. UACR was positively correlated with hsCRP 
(r = 0.180; P = 0.044), Gensini score (r = 0.451; P < 0.001) and 
the number of DCA (r= 0.279; P = 0.002), and negatively cor-
related with HRR (r = -0.192; P = 0.042) and DTS (r = -0.212; 
P = 0.017); moreover, hsCRP was negatively correlated with 
HRR (r = -0.187; P = 0.034) and DTS (r = -0.326; P < 0.001) in 
patients with lower HRR. We did not observe any associations 
among the above remarked variables in patients with higher 
HRR. Table 3 shows the results of univariate and multivariate 
analyses to define the independent predictors of the presence of 
lower HRR in all patients with non-obstructive CAD. UACR 
and hsCRP were independently associated with the presence 
of lower HRR (UACR: OR: 0.988; 95% CI: 0.983 - 0.993; P 
< 0.001 and hsCRP: OR: 0.807; 95% CI: 0.735 - 0.886; P < 
0.001). Figure 1 displays ROC curve analysis of UACR for 
predicting lower HRR value in all patients with non-obstruc-
tive CAD. This analysis indicated that an UACR of 9.7 mg/g 
or higher predicted the presence of a lower HRR with a maxi-
mal sensitivity of 71% and specificity of 58% (AUC: 0.68; CI: 
0.62 - 0.74; P < 0.001).
Discussion
Our results revealed that greater autonomic dsyfunction (lower 
HRR) was observed in patients with microalbuminuria than 
patients without microalbuminuria. Moreover, the key finding 
of our study was that while UACR was negatively correlated 
with HRR in patients with microalbuminuria, it was not cor-
related with HRR in patients without microalbuminuria, sug-
gesting that albumin excretion could be related to cardiac auto-
nomic dysfunction in this group of patients. To our knowledge, 
this is the first report demonstrating an important association 
between microalbuminuria and abnormal HRR after exercise 
in patients with non-obstructive CAD.
In this study, diabetic, hypertensive and obese patients 
were excluded in order to eliminate their potential confound-
ing effects on albuminuria and autonomic function. In addi-
tion, the levels of blood pressure in the groups were within the 
normotensive range. Therefore, this study may not suggest dia-
betes, hypertension, and obesity as the factors playing role in 
the association of microalbuminuria and lower HRR. Several 
reasons may explain this association in non-obstructive CAD 
patients. First, albuminuria might be associated with the extent 
and severity of the underlying coronary disease. We observed 
that patients with microalbuminuria had higher Gensini score 
and more multi-vessel disease than those without microalbumi-
nuria, and that there was a strong association between Gensini 
score and UACR in patients with microalbuminuria, but not in 
patients without microalbuminuria. Hoseini et al showed that 
the patients with microalbuminuria had much greater athero-
sclerotic burden in the form of multi-vessel disease than those 
without microalbuminuria [18]. In another study, Rein et al 
investigated whether albuminuria was associated with ≥ 50% 
coronary artery stenosis and they showed that albuminuria was 
strongly associated with angiographically detected coronary 
atherosclerosis in 914 patients with or without type 2 diabetes 
mellitus, and they also found that the prevalence of stenoses 
≥ 50% increased significantly from patients with normoalbu-
minuria over those with microalbuminuria to those with mac-
roalbuminuria [19]. These findings are in line with the current 
study. Although abnormal HRR was not helpful in determining 
the presence of the underlying significant CAD, it might be as-
sociated with the greater extent of CAD [13]. We found that pa-
tients with abnormal HRR had higher Gensini score and more 
multi-vessel disease than patients with normal HRR values. In 
Table 3.  Independent Predictors of the Presence of Lower HRR Value (≤ 12 beats/min) in Patients With Non-Obstructive Coronary 
Artery Disease
Variables
Univariate analysis Multivariate analysis
Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Age 0.967 (0.941 - 0.995) 0.021 0.972 (0.943 - 1.003) 0.073
LDL 0.990 (0.983 - 0.998) 0.009 0.995 (0.986 - 1.005) 0.364
Triglyceride 0.993 (0.988 - 0.998) 0.006 0.995 (0.989 - 1.001) 0.125
Glucose 0.977 (0.955 - 0.998) 0.036 0.976 (0.952 - 1.001) 0.055
hsCRP 0.769 (0.706 - 0.837) < 0.001 0.807 (0.735 - 0.886) < 0.001
UACR 0.983 (0.979 - 0.988) < 0.001 0.988 (0.983 - 0.993) < 0.001
Gensini score 0.983 (0.977 - 0.989) < 0.001 0.995 (0.986 - 1.004) 0.254
The number of DCA 0.623 (0.470 - 0.825) 0.001 0.864 (0.602 - 1.239) 0.426
Duke treadmill score 1.040 (1.015 - 1.066) 0.002 1.010 (0.981 - 1.040) 0.496
CI: confidence interval; HRR: heart rate recovery; hsCRP: high-sensitive C-reactive protein; DCA: diseased coronary arteries; LDL: low-densitiy 
lipoprotein; UACR: urinary albumin-to-creatinine ratio.
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a study by Ghaffari et al, patients with abnormal HRR were 
more likely to have more severe coronary disease than those 
with normal HRR [10]. We also found that both patients with 
abnormal HRR and patients with microalbuminuria had higher 
UACR and less DTS score than those of counterparts, indicat-
ing that both cardiac autonomic dysfunction and microalbumi-
nuria make these patients more prone to myocardial ischemia 
during exercise stress test. A previous study showed that pa-
tients with abnormal HRR had a greater degree of myocardial 
ischemia on myocardial scintigraphy during exercise [9]. Very 
recently, Osugi et al assessed the impact of albuminuria on the 
incidence of periprocedural myocardial injury in patients who 
underwent elective percutaneous coronary intervention, and 
showed that patients with albuminuria had a 4.2-fold higher 
risk for periprocedural myocardial infarction than did patients 
with normoalbuminuria [20]. All these data could suggest that 
both albuminuria and abnormal HRR in non-obstructive CAD 
patients might share common pathophysiologic pathway, con-
sisting of endothelial damage, high atherosclerotic and thus, 
ischemic burden, which was closely associated with cardiac 
autonomic impairment.
Second, the underlying chronic inflammation might be re-
sponsible for both microalbuminuria and abnormal HRR in this 
patient population. We observed that patients with microalbu-
minuria had greater hsCRP values than patients without micro-
albuminuria. Another important finding in our study was that 
patients with abnormal HRR had greater hsCRP values than 
patients with normal HRR. Moreover, we found that UACR 
and hsCRP were independent predictors of the presence of ab-
normal HRR in non-obstructive CAD patients, suggesting that 
albumin excretion and systemic inflammation and their inter-
action could have significant effects on autonomic dysfunc-
tion. Elevations of inflammatory mediators might directly alter 
glomerular function and thus, might be causally involved in 
the development of microalbuminuria. Serum hsCRP has been 
associated with vascular inflammation, and significantly corre-
lated with microalbuminuria in the general population [21]. In 
the former studies, urinary albumin excretion has been shown 
to increase in diabetic and non-diabetic patients [5-8], inflam-
matory diseases [22, 23], and acute myocardial infarction as 
well [24]. A growing number of evidence in recent years has 
demonstrated that cardiac autonomic nervous activity, as eval-
uated by heart rate variability (HRV) and HRR, is associated 
with inflammatory markers [25, 26]. More recently, we have 
shown that impaired cardiac autonomic function, as evidenced 
by a slower HRR, is closely related to inflammatory markers 
such as hsCRP in both CAD and cardiac syndrome X [11].
Third, cardiac autonomic dysfunction may play a direct 
causative role in renal disease beacuse the renal vasculature 
is extensively innervated by the sympathetic nervous system 
Figure 1. ROC curve analysis of UACR for predicting lower HRR value in all patients with non-obstructive CAD. CAD: coronary 
artery disease; HRR: heart rate recovery; UACR: urinary albumin-to-creatinine ratio.
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[27]. Although we did not search such a causality between al-
buminuria and autonomic function in our study, our findings 
could still be useful in understanding why albuminuria was 
associated with abnormal HRR. Moran et al conducted a study 
on whether cardiovascular autonomic neuropathy, assessed by 
HRV, was related to microalbuminuria in young and middle-
aged patients with type 2 diabetes, and they found that cardiac 
autonomic dysfunction was independently associated with 
increased albuminuria [28]. Recently, Maguire et al showed 
that abnormal pupillary response, a marker of autonomic dys-
function, preceded the development of microalbuminuria and 
diabetic retinopathy 12 years later [29]. These results could 
suggest that damage to the autonomic nerves purveying the 
renal vasculature might pave the way for increased renal blood 
flow, glomerular hyperfiltration, and, thus, microalbuminuria, 
as suggested previously by some authors.
Study strengths and limitations
The strengths of the present study were as follows: first, its 
large sample size; second, the careful selection and the angio-
graphical characterization of the recruited participants; third, 
the use of at least two morning urine samples to determine the 
presence of albuminuria. However, it had several limitations. 
First, since the population studied was highly selected, our re-
sults might not be applicable to other populations; second, our 
study had cross-sectional design without long-term follow-up 
data, not allowing to define causality. Lastly, we did not specif-
ically carry out intravascular studies to fully define the degree 
of coronary stenosis or characterize the plaque burden.
Conclusion
We found that non-obstructive CAD patients with microalbu-
minuria had lower HRR value, and non-obstructive CAD pa-
tients with abnormal HRR had higher UACR when compared 
to counterparts. We also found that there was a significant in-
verse association between UACR and HRR in patients particu-
larly with microalbuminuria, and that albuminuria might pre-
dict cardiac autonomic imbalance assessed by HRR in patients 
with non-obstructive CAD. If our findings can be confirmed by 
prospective randomized large-scale studies, the routine meas-
urement and detection of these high risk parameters (micro-
albuminuria and abnormal HRR after exercise) in this patient 
population could be applied into clinical practice.
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